If a patient is paying cash for C-II drugs, what should the pharmacist do regarding the brand or generic?

In situations where a patient is paying cash for a Schedule II (C-II) drug, it is important for the pharmacist to involve the patient in the decision regarding whether to dispense a brand-name or a generic medication. By asking the patient for their preference, the pharmacist empowers them to make an informed choice based on their individual needs, which can include factors such as cost, past experiences with a specific formulation, or preferences for brand recognition.

Engaging the patient in this manner fosters a collaborative pharmacist-patient relationship and ensures that the dispensed medication aligns with the patient's comfort and expectations. This approach is consistent with patient-centered care practices, which prioritize the preferences and values of the patient in the decision-making process regarding their healthcare.

Other options may not adequately address the patient's needs or preferences, as not all patients will automatically prefer the cheaper option or want a generic without consideration of quality and effectiveness as per their past experiences. Therefore, discussing options with the patient promotes transparency and trust.